Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tramway Venture Partners is a venture capital firm founded in 2017 in Albuquerque, New Mexico. The firm focuses on building disruptive life science companies, leveraging the state's technology-rich environment and research institutions. Tramway aims to capitalize on the unique resources available in New Mexico, including partnerships with local universities and national laboratories.
Currently, Tramway manages a portfolio of seven companies and is actively raising its third fund, targeting $40 million. The New Mexico State Investment Council has committed $20 million to this fund, which will primarily deploy 90% of its capital within the state. Tramway's investment strategy emphasizes early-stage opportunities, particularly in the biotech and healthcare sectors.
Tramway Venture Partners invests in seed and early-stage life science companies, specifically targeting opportunities at the intersection of physical sciences, information technology, and healthcare. The firm typically engages in the first institutional round of funding after incubators and angel investors, focusing on companies that exhibit strong management teams, significant intellectual property, and clear market strategies.
Investment checks can reach up to $30 million, with a preference for companies that have large addressable markets. Tramway's strategy is to identify ventures that require less than $30 million to exit, ensuring a clear path to profitability and growth. The firm is particularly interested in companies that leverage New Mexico's unique technological and research capabilities.
Tramway Venture Partners has invested in several notable companies, including:
These companies represent Tramway's commitment to advancing life sciences through innovative technologies and solutions.
Waneta Tuttle: Founder and Managing Partner. Waneta has extensive experience in venture capital and life sciences, having led numerous successful investments in the sector.
Katie Rice: Managing Partner. Katie brings a wealth of knowledge in healthcare investments and has a strong track record in supporting early-stage companies.
Chris Japp: Managing Partner, appointed in August 2023. Chris has a background in technology commercialization and has been instrumental in expanding Tramway's portfolio.
John Rockwell: Venture Partner. John has significant experience in biotech and has been involved in various successful exits.
Stu Rose: Venture Partner. Stu specializes in healthcare investments and has a strong network in the industry.
Brad Vale: Venture Partner. Brad has a background in operational roles within startups and provides valuable insights to portfolio companies.
Joseph Juang: Principal. Joseph focuses on sourcing new investment opportunities and conducting due diligence.
Dee Brescia, CPA: Administrative Services. Dee manages the firm's administrative functions and financial reporting.
To pitch Tramway Venture Partners, founders should visit their contact page at Tramway Ventures Contact Page. It is recommended to include a comprehensive business plan and a clear presentation of the technology's unique aspects. Tramway prefers detailed decks that outline market strategies and potential for growth.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In 2024, Tramway Venture Partners announced two new investments: Nob Hill Therapeutics and Circular Genomics. These investments reflect Tramway's ongoing commitment to supporting innovative life science companies.
Tramway has also been actively building its portfolio, which includes notable companies such as BennuBio and Breezy Med. The firm continues to leverage New Mexico's technology-rich environment to identify promising ventures.
What are Tramway Venture Partners' investment criteria?
Tramway focuses on seed and early-stage life science companies, particularly those at the intersection of physical sciences, information technology, and healthcare. They look for strong management teams, significant intellectual property, and clear market strategies.
How can I pitch Tramway Venture Partners?
Founders can pitch Tramway by visiting their contact page at Tramway Ventures Contact Page. It is advisable to include a detailed business plan and highlight the unique aspects of your technology.
What makes Tramway different from other venture capital firms?
Tramway leverages New Mexico's technology-rich environment and research institutions, focusing specifically on life sciences. Their deep connections within the local ecosystem provide unique advantages for portfolio companies.
What is the typical check size Tramway invests?
Tramway typically invests up to $30 million in their portfolio companies, particularly in the first institutional round after angel and incubator funding.
What geographic areas does Tramway focus on?
Tramway primarily invests in companies based in the United States, with a strong emphasis on opportunities within New Mexico.
What kind of post-investment support does Tramway provide?
Tramway actively engages with its portfolio companies, providing mentorship, operational support, and access to their extensive network in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.